Press/Media
- 1 - 25 out of 48 results
Search results
-
University of los Andes Researcher Has Provided New Data on Tissue Engineering (Understanding the Molecular Conformation and Viscoelasticity of Low Sol-Gel Transition Temperature Gelatin Methacryloyl Suspensions)
Paulo César Díaz Calderón, Javier Ignacio Enrione, Juan Pablo Acevedo & Cristina Padilla
10/05/23
1 item of Media coverage
Press/Media
-
Long Covid: What is the disease affecting former minister Uriarte?
20/04/23
1 item of Media coverage
Press/Media
-
Long Covid made a minister of Gabriel Boric's cabinet resign
20/04/23
1 item of Media coverage
Press/Media
-
Findings from University of los Andes Advance Knowledge in Acute Respiratory Distress Syndrome (Safety and efficacy of clinical-grade, cryopreserved menstrual blood mesenchymal stromal cells in experimental acute respiratory distress syndrome)
Francisca Alcayaga-Miranda & Maroun Khoury
10/02/23
1 item of Media coverage
Press/Media
-
US Patent Issued to UNIVERSIDAD DE LOS ANDES, CELLS FOR CELLS on Jan. 31 for "Gelatin polymer derived from natural sources of cold-adapted marine species and uses thereof" (Chilean Inventors)
Paulo César Díaz Calderón, Javier Ignacio Enrione & Juan Pablo Acevedo
1/02/23
1 item of Media coverage
Press/Media
-
Israeli scientists identify a protein involved in aging in mice
27/01/23
1 item of Media coverage
Press/Media
-
Bivalent vaccine against covid: specialists accuse slowness and point to communication strategy | National
24/01/23
1 item of Media coverage
Press/Media
-
Data on Climate Change Detailed by Researchers at University of los Andes (Climate change and preterm birth: A narrative review)
9/12/22
1 item of Media coverage
Press/Media
-
Record number of coronavirus cases in China complicates "zero covid" policy
25/11/22
1 item of Media coverage
Press/Media
-
El Polígrafo analyzes misinformation about bivalent vaccine
2/11/22
1 item of Media coverage
Press/Media
-
Patient Dosed With Mesenchymal Stem Cell-Derived Therapy for Osteoarthritis
25/07/22
1 item of Media coverage
Press/Media
-
CELLS For CELLS Treats The First-Ever Patient With An Exosome-Produced Therapy For Osteoarthritis
18/07/22 → 19/07/22
19 items of Media coverage
Press/Media
-
Cells for Cells treats first patient with exosome-produced therapy for osteoarthritis
19/07/22
1 item of Media coverage
Press/Media
-
CELLS for CELLS Treats the First-Ever Patient with an Exosome-Produced Therapy for Osteoarthritis
19/07/22
1 item of Media coverage
Press/Media
-
CELLS For CELLS Treats The First-Ever Patient With An Exosome-Produced Therapy For Osteoarthritis
18/07/22
1 item of Media coverage
Press/Media
-
More than 48,000 people have required emergency mental health care this year.
19/03/22
1 item of Media coverage
Press/Media
-
Cell for Cells starts cell therapy operations in the U.S. and closes agreement with the University of Miami
18/02/22
1 item of Media coverage
Press/Media
-
Demand for home PCR increases due to rise in number of infected patients
3/02/22
1 item of Media coverage
Press/Media
-
-
Revolutionary Chilean center will research the generation of new tissues and the use of cells to treat patients
2/01/22
1 item of Media coverage
Press/Media
-
US Patent Issued to Cells for Cells on June 22 for "Anti-angiogenic therapy based on exosomes derived from menstrual stem cells" (Chilean Inventors)
23/06/21
1 item of Media coverage
Press/Media
-
People with a history of bleeding can inoculate with AstraZeneca
8/05/21
1 item of Media coverage
Press/Media
-
Concern in Chile about the follow-up of fights with saña and blood that are repeated in streets and public places
25/01/21
1 item of Media coverage
Press/Media